HRP20090594T1 - Upotreba aktiviranih polimera za odvajanje proteina i polipeptidnih multimera - Google Patents
Upotreba aktiviranih polimera za odvajanje proteina i polipeptidnih multimera Download PDFInfo
- Publication number
- HRP20090594T1 HRP20090594T1 HR20090594T HRP20090594T HRP20090594T1 HR P20090594 T1 HRP20090594 T1 HR P20090594T1 HR 20090594 T HR20090594 T HR 20090594T HR P20090594 T HRP20090594 T HR P20090594T HR P20090594 T1 HRP20090594 T1 HR P20090594T1
- Authority
- HR
- Croatia
- Prior art keywords
- group
- mpeg
- polypeptide
- use according
- activated polymer
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title claims abstract 24
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract 24
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract 24
- 229920000642 polymer Polymers 0.000 title claims abstract 18
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 238000000926 separation method Methods 0.000 title 1
- 125000003172 aldehyde group Chemical group 0.000 claims 5
- 125000003277 amino group Chemical group 0.000 claims 5
- 239000000126 substance Substances 0.000 claims 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 4
- ASUGWWOMVNVWAW-UHFFFAOYSA-N 1-(2-methoxyethyl)pyrrole-2,5-dione Chemical compound COCCN1C(=O)C=CC1=O ASUGWWOMVNVWAW-UHFFFAOYSA-N 0.000 claims 3
- 150000001720 carbohydrates Chemical class 0.000 claims 3
- 235000014633 carbohydrates Nutrition 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 3
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 239000007864 aqueous solution Substances 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000000468 ketone group Chemical group 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 claims 1
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Natural products CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 claims 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims 1
- 150000001299 aldehydes Chemical class 0.000 claims 1
- 125000003636 chemical group Chemical group 0.000 claims 1
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical group C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 claims 1
- 125000003700 epoxy group Chemical group 0.000 claims 1
- -1 hydroxysuccinimidyl group Chemical group 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 229920001427 mPEG Polymers 0.000 claims 1
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 claims 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 claims 1
- 230000002829 reductive effect Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05003332 | 2005-02-16 | ||
| PCT/EP2006/001359 WO2006087178A1 (en) | 2005-02-16 | 2006-02-15 | Use of activated polymers for separation of protein and polypeptide multimers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20090594T1 true HRP20090594T1 (hr) | 2009-12-31 |
Family
ID=36168573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20090594T HRP20090594T1 (hr) | 2005-02-16 | 2009-11-04 | Upotreba aktiviranih polimera za odvajanje proteina i polipeptidnih multimera |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080312411A1 (sl) |
| EP (1) | EP1848458B1 (sl) |
| JP (1) | JP2008530163A (sl) |
| AT (1) | ATE447414T1 (sl) |
| AU (2) | AU2006215823A1 (sl) |
| CA (1) | CA2594666A1 (sl) |
| DE (1) | DE602006010176D1 (sl) |
| DK (1) | DK1848458T3 (sl) |
| ES (1) | ES2335304T3 (sl) |
| HR (1) | HRP20090594T1 (sl) |
| SI (1) | SI1848458T1 (sl) |
| WO (1) | WO2006087178A1 (sl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5766118B2 (ja) * | 2008-09-11 | 2015-08-19 | ウェルズ ファーゴ バンク ナショナル アソシエイション | ポリマー性アルファ−ヒドロキシアルデヒドおよびケトン反応剤ならびに抱合方法 |
| US9315514B2 (en) | 2012-08-27 | 2016-04-19 | Rhodes Technologies | 1,3-dioxanomorphides and 1,3-dioxanocodides |
| EP2931725B1 (en) | 2012-12-14 | 2017-02-15 | Purdue Pharma LP | Nitrogen containing morphinan derivatives and the use thereof |
| US8987287B2 (en) | 2012-12-14 | 2015-03-24 | Purdue Pharma L.P. | Spirocyclic morphinans and their use |
| ES2631197T3 (es) | 2012-12-14 | 2017-08-29 | Purdue Pharma Lp | Análogos de piridonamorfinano y actividad biológica sobre los receptores opiodes |
| CA2896202A1 (en) | 2012-12-28 | 2014-07-03 | Purdue Pharma L.P. | Substituted morphinans and the use thereof |
| TW201441198A (zh) | 2012-12-28 | 2014-11-01 | Purdue Pharma Lp | ７，８－環嗎啡喃類似物 |
| AU2013369037C1 (en) | 2012-12-31 | 2017-06-08 | Rhodes Technologies | Process for preparing 7beta-substituted 6alpha,14alpha -ethenomorphinans and 7beta-substituted 6alpha,14alpha-ethanomorphinans |
| WO2015097546A1 (en) | 2013-12-26 | 2015-07-02 | Purdue Pharma L.P. | Propellane-based compounds and their use as opioid receptor modulators |
| WO2015097545A1 (en) | 2013-12-26 | 2015-07-02 | Purdue Pharma L.P. | Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans |
| EP3087073B1 (en) | 2013-12-26 | 2018-07-04 | Purdue Pharma LP | 10-substituted morphinan hydantoins |
| US9988392B2 (en) | 2013-12-26 | 2018-06-05 | Purdue Pharma L.P. | 7-beta-alkyl analogs of orvinols |
| WO2015102682A1 (en) | 2013-12-30 | 2015-07-09 | Purdue Pharma L.P. | Pyridone-sulfone morphinan analogs as opioid receptor ligands |
| SI3559010T1 (sl) | 2016-12-23 | 2022-10-28 | Minoryx Therapeutics S. L. | Postopek za pripravo 5-((4-(2-(5-(1-hidroksietil)-2-piridinil)etoksi) fenil)metil)-2,4-tiazolidindiona in soli le-tega |
| US11845759B2 (en) | 2018-02-23 | 2023-12-19 | Rhodes Technologies | Opioid compounds and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5312808A (en) * | 1989-11-22 | 1994-05-17 | Enzon, Inc. | Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
| EP1324779B1 (en) * | 2000-09-29 | 2011-07-20 | Schering Corporation | Pegylated interleukin-10 |
| KR20040069980A (ko) * | 2001-06-22 | 2004-08-06 | 파마시아 코포레이션 | 화학적으로 변형된 프로게니포이에틴 접합체 |
-
2006
- 2006-02-15 US US11/884,300 patent/US20080312411A1/en not_active Abandoned
- 2006-02-15 WO PCT/EP2006/001359 patent/WO2006087178A1/en active Application Filing
- 2006-02-15 CA CA002594666A patent/CA2594666A1/en not_active Abandoned
- 2006-02-15 AT AT06706962T patent/ATE447414T1/de active
- 2006-02-15 ES ES06706962T patent/ES2335304T3/es active Active
- 2006-02-15 JP JP2007555522A patent/JP2008530163A/ja not_active Withdrawn
- 2006-02-15 DK DK06706962.5T patent/DK1848458T3/da active
- 2006-02-15 EP EP06706962A patent/EP1848458B1/en active Active
- 2006-02-15 DE DE602006010176T patent/DE602006010176D1/de active Active
- 2006-02-15 SI SI200630466T patent/SI1848458T1/sl unknown
- 2006-02-15 AU AU2006215823A patent/AU2006215823A1/en not_active Abandoned
-
2007
- 2007-11-27 AU AU2007237199A patent/AU2007237199A1/en not_active Withdrawn
-
2009
- 2009-11-04 HR HR20090594T patent/HRP20090594T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006215823A1 (en) | 2006-08-24 |
| DK1848458T3 (da) | 2010-02-01 |
| AU2007237199A1 (en) | 2008-01-17 |
| ATE447414T1 (de) | 2009-11-15 |
| CA2594666A1 (en) | 2006-08-24 |
| DE602006010176D1 (de) | 2009-12-17 |
| ES2335304T3 (es) | 2010-03-24 |
| SI1848458T1 (sl) | 2010-01-29 |
| EP1848458B1 (en) | 2009-11-04 |
| US20080312411A1 (en) | 2008-12-18 |
| WO2006087178A1 (en) | 2006-08-24 |
| EP1848458A1 (en) | 2007-10-31 |
| JP2008530163A (ja) | 2008-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20090594T1 (hr) | Upotreba aktiviranih polimera za odvajanje proteina i polipeptidnih multimera | |
| Kumar et al. | Antimicrobial peptide–polymer conjugates with high activity: Influence of polymer molecular weight and peptide sequence on antimicrobial activity, proteolysis, and biocompatibility | |
| Oupický et al. | Laterally stabilized complexes of DNA with linear reducible polycations: strategy for triggered intracellular activation of DNA delivery vectors | |
| Hou et al. | A concise approach to site-specific topological protein–poly (amino acid) conjugates enabled by in situ-generated functionalities | |
| Kamada et al. | Synthesis of a poly (vinylpyrrolidone-co-dimethyl maleic anhydride) co-polymer and its application for renal drug targeting | |
| Kopeček et al. | Water soluble polymers in tumor targeted delivery | |
| Unsworth et al. | Protein-resistant poly (ethylene oxide)-grafted surfaces: chain density-dependent multiple mechanisms of action | |
| Xu et al. | Antifouling surfaces enabled by surface grafting of highly hydrophilic sulfoxide polymer brushes | |
| Keefe et al. | Poly (zwitterionic) protein conjugates offer increased stability without sacrificing binding affinity or bioactivity | |
| Matsuura et al. | l-Serine–modified polyamidoamine dendrimer as a highly potent renal targeting drug carrier | |
| Huang et al. | Conjugation of hyaluronic acid onto surfaces via the interfacial polymerization of dopamine to prevent protein adsorption | |
| Ahmed et al. | Hyperbranched glycopolymers for blood biocompatibility | |
| Yu et al. | Proteins conjugated with sulfoxide-containing polymers show reduced macrophage cellular uptake and improved pharmacokinetics | |
| JP2018118953A5 (sl) | ||
| Chen et al. | Polyion complex micelles for protein delivery | |
| WO2008047241A3 (en) | Modified corticotropin releasing factor peptides and uses thereof | |
| KR101512702B1 (ko) | 금속 나노 입자 기반 간 표적 지향 약물 전달체 및 이의 제조방법 | |
| WO2011017055A3 (en) | Blood coagulation protein conjugates | |
| WO2008069824A3 (en) | Compositions and methods for transport of molecules with enhanced release properties across biological barriers | |
| ATE374650T1 (de) | Verbesserungen bei polymerteilchen | |
| Wang et al. | Recent advances and biomedical applications of peptide-integrated conducting polymers | |
| Rivas et al. | Functional water‐soluble polymers: polymer–metal ion removal and biocide properties | |
| EP3093029A8 (en) | Blood coagulation protein conjugates | |
| Liu et al. | Self-assembling protein–polymer bioconjugates for surfaces with antifouling features and low nonspecific binding | |
| Liu et al. | Serum albumin–peptide conjugates for simultaneous heparin binding and detection |